Janney Montgomery Scott LLC Enanta Pharmaceuticals Inc Transaction History

Janney Montgomery Scott LLC

  • $35.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
BUY
$11.09 - $22.13 $692,592 - $1.38 Million
62,452 New
62,452 $698,000
Q3 2018

Nov 05, 2018
SELL
$85.46 - $126.37 $261,934 - $387,324
-3,065 Closed
0 $0
Q1 2018

Apr 19, 2018
BUY
$57.91 - $92.15 $177,494 - $282,439
3,065 New
3,065 $248,000

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email